Effect of aerobic training on the host systemic milieu in patients with solid tumours: An exploratory correlative study

British Journal of Cancer

Volumn 112, Issue 5, 2015, Pages 825-831

  Glass, O K ^a   Inman, B A ^a   Broadwater, G ^a   Courneya, K S ^b   Mackey, J R ^b   Goruk, S ^b   Nelson, E R ^a   Jasper, J ^a   Field, C J ^b   Bain, J R ^a   Muehlbauer, M ^a   Stevens, R D ^a   Hirschey, M D ^a   Jones, L W ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ANGIOGENIC FACTOR; CD45RA ANTIGEN; CYTOKINE; FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 4; KETONE; LACTIC ACID; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PHOSPHATE; RECOMBINANT ERYTHROPOIETIN; SCATTER FACTOR; SOMATOMEDIN C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTINEOPLASTIC AGENT; ERYTHROPOIETIN; TUMOR MARKER;

ADULT; AEROBIC EXERCISE; ARTICLE; BICYCLE ERGOMETRY; BLOOD SAMPLING; CANCER PATIENT; CARDIOPULMONARY FUNCTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNITY; MALE; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; SOLID TUMOR; THERAPY EFFECT; BLOOD; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL (TOPIC); EXERCISE TEST; KINESIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASMS; PILOT STUDY; PROCEDURES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OXYGEN CONSUMPTION; PILOT PROJECTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84928697199     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.662     Document Type: Article

References (29)

1. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, Mctiernan A, Alfano CM (2012) Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 104: 815-840.
2. Barcellos-Hoff MH, Lyden D, Wang TC (2013) The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer 13: 511-518.
3. Betof AS, Dewhirst MW, Jones LW (2013) Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. Brain Behav Immun 30(Suppl): S75-S87.
4. Cappello P, Novelli F, Forni G, Giovarelli M (2002) Death receptor ligands in tumors. J Immunother 25: 1-15.
5. Courneya KS, Jones LW, Peddle CJ, Sellar CM, Reiman T, Joy AA, Chua N, Tkachuk L, Mackey JR (2008) Effects of aerobic exercise training in anemic cancer patients receiving darbepoetin alfa: a randomized controlled trial. Oncologist 13: 1012-1020.
6. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR (2005) Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol (1985), 98 1534-1540.
7. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N (2012) Insulin-and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30: 164-171.
8. Hursting SD, Berger NA (2010) Energy balance, host-related factors, and cancer progression. J Clin Oncol 28: 4058-4065.
9. Jones LW, Alfano CM (2013) Exercise-oncology research: past, present, and future. Acta Oncol 52: 195-215.
10. Jones LW, Fels DR, West M, Broadwater G, Barry WT, Wilke LG, Masko EM, Douglas P, Dash R, Povsic T, Peppercorn J, Marcom K, Blackwell K, Kimmick G, Dewhirst MW (2013a) Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) 6: 925-937.
11. Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, Haykowsky M (2011) Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist 16: 112-120.
12. Jones SB, Thomas GA, Hesselsweet SD, Alvarez-Reeves M, Yu H, Irwin ML (2013b) Effect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study. Cancer Prev Res (Phila) 6: 109-118.
13. Joyner MJ, Green DJ (2009) Exercise protects the cardiovascular system: effects beyond traditional risk factors. J Physiol 587: 5551-5558.
14. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H (2009) Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301: 2024-2035.
15. LaMontagne KR, Butler J, Marshall DJ, Tullai J, Gechtman Z, Hall C, Meshaw A, Farrell FX (2006) Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models. Mol Cancer Ther 5: 347-355.
16. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Lancet Physical Activity Series Working Group (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380: 219-229.
17. Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, Souza A, Cheng S, Mccabe EL, Yang E, Shi X, Deo R, Roth FP, Asnani A, Rhee EP, Systrom DM, Semigran MJ, Vasan RS, Carr SA, Wang TJ, Sabatine MS, Clish CB, Gerszten RE (2010) Metabolic signatures of exercise in human plasma. Sci Transl Med 2: 33ra37.
18. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117: 1175-1183.
19. McAllister SS, Gifford AM, Greiner AL, Kelleher SP, Saelzler MP, Ince TA, Reinhardt F, Harris LN, Hylander BL, Repasky EA, Weinberg RA (2008) Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133: 994-1005.
20. McAllister SS, Weinberg RA (2010) Tumor-host interactions: a far-reaching relationship. J Clin Oncol 28: 4022-4028.
21. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard CB, Heath AC, Gordon JI (2011) The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106ra106.
22. Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480: 480-489.
23. Shah SH, Sun JL, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, Haynes C, Hauser ER, Kraus WE, Granger CB, Newgard CB, Califf RM, Newby LK (2012) Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J 163: 844-850 e1.
24. Sheen-Chen SM, Chen WJ, Eng HL, Chou FF (1997) Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 43: 211-215.
25. Sheen-Chen SM, Liu YW, Eng HL, Chou FF (2005) Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 14: 715-717.
26. Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4: 87-100.
27. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487: 500-504.
28. Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, Azevedo MJ, Gross JL, Ribeiro JP, Schaan BD (2011) Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 305: 1790-1799.
29. Zhang GJ, Adachi I (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19: 1427-1432.